Drug Designing

Drug designing is an inventive process of finding new medication based on the target knowledge. A drug is commonly a small compound which produces a therapeutic effect. There are different methods of drug designing. Designing a drug based on the three dimensional structure and computational techniques are known as structure based drug design and computer aided drug design respectively. There are various stages involved in computer aided drug design such as hit identification, hit to lead optimization and lead optimization. In structure based drug design, the structure is obtained either through x-ray crystallography or NMR spectroscopy. Ligand-based drug design depends on the knowledge of molecules that bind to the biological target of our interest. Correlation between calculated and theoretical can be derived and this QSAR relationship is used to derive analogs.

  • Structure Based Drug Design
  • Ligand Based Drug Design
  • Drug Interactions
  • Virtural Screening and Drug Design
  • Computation Biology for Drug Target Identification and Validation
  • Nanomedicine

Related Conference of Drug Designing

May 10-11, 2019

8th Asia Pacific Glycobiology Congress

Tokyo, Japan
July 11-12, 2019

8th Glycobiology World Congress

Zurich, Switzerland
May 10-11, 2019

4th International Conference on Enzymology & Molecular Biology

| Radisson Hotel Narita | Tokyo, Japan
October 07-08, 2019

4th International Conference on Molecular Biology & Nucleic Acids

Chicago, Illinois, USA

Drug Designing Conference Speakers

Recommended Sessions

Related Journals

Are you interested in